Gross Margin % is calculated as gross profit divided by its revenue. BioLargo's Gross Profit for the
three
months ended in Dec. 2023 was $2.09 Mil. BioLargo's Revenue for the
three
months ended in Dec. 2023 was $4.37 Mil. Therefore, BioLargo's Gross Margin % for the quarter that ended in Dec. 2023 was 47.78%.
The historical rank and industry rank for BioLargo's Gross Margin % or its related term are showing as below:
BLGO'
s Gross Margin % Range Over the Past 10 Years
Min: 37.4 Med: 49.61 Max: 62.28
Current: 50.3
During the past 13 years, the highestGross Margin % of BioLargo was 62.28%. The lowest was 37.40%. And the median was 49.61%.
BLGO's Gross Margin % is ranked better than 92.64% of 1508
companies
in the Chemicals industry
Industry Median: 22.205
vs BLGO: 50.30
BioLargo had a gross margin of 47.78% for the quarter that ended in Dec. 2023 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for BioLargo was 0.90% per year.
BioLargo Gross Margin % Historical Data
The historical data trend for BioLargo's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioLargo's Gross Margin %
For the Chemicals subindustry, BioLargo's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioLargo's Gross Margin % Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, BioLargo's Gross Margin % distribution charts can be found below:
* The bar in red indicates where BioLargo's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
BioLargo (OTCPK:BLGO) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
BioLargo had a gross margin of 47.78% for the quarter that ended in Dec. 2023 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
BioLargo Gross Margin % Related Terms
Thank you for viewing the detailed overview of BioLargo's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
BioLargo Inc invents, develops, and commercializes platform technologies to solve challenging environmental problems like PFAS contamination, advanced water, and wastewater treatment, industrial odor, and VOC control, air quality control, and infection control. The company holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. BioLargo invents or acquires novel technologies and develops them to maturity through its operating subsidiaries. It monetizes through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation, and/or the sale of the IP. The firm's technologies are commercially available and are advancing as disrupters in their respective markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BLGO has been successfully added to your 